Robert Dreicer
University of Virginia School of Medicine

Last Updated On 5/27/2022 3:53:21 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.

Employment
No Relationships to Disclose

Leadership
No Relationships to Disclose

Stock and Other Ownership Interests
No Relationships to Disclose

Honoraria
No Relationships to Disclose

Consulting or Advisory Role
Company: Astellas Pharma
Recipient: You
Company: Pfizer
Recipient: You
Company: Merck
Recipient: You
Company: EMD Serono
Recipient: You
Company: Propella
Recipient: You
Company: Myovant
Recipient: You
Company: Bayer
Recipient: You
Company: AstraZeneca
Recipient: You
Company: AVEO
Recipient: You
Company: Exelixis
Recipient: You
Company: bristol -Myers Squibb
Recipient: You
Company: Hinova Pharmaceuticals
Recipient: You
Company: Janssen Oncology
Recipient: You
Company: Myovant Sciences
Recipient: You
Company: Seattle Genetics
Recipient: You
Company: Hengrui Pharmaceutical
Recipient: You
Company: Tavanta
Recipient: You
Company: Gilead Sciences
Recipient: You

Speakers' Bureau
No Relationships to Disclose

Research Funding
Company: Seattle Genetics
Recipient: Your Institution
Company: Bristol-Myers Squibb
Recipient: Your Institution
Company: Exelixis
Recipient: Your Institution
Company: Novartis
Recipient: Your Institution

Patents, Royalties, Other Intellectual Property
No Relationships to Disclose

Expert Testimony
No Relationships to Disclose

Travel, Accommodations, Expenses
No Relationships to Disclose

Other Relationship
No Relationships to Disclose

(OPTIONAL) Uncompensated Relationships
not answered

(OPTIONAL) Open Payments Link
not answered